Liana Hsu

1.7k total citations · 1 hit paper
18 papers, 612 citations indexed

About

Liana Hsu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Liana Hsu has authored 18 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 8 papers in Genetics. Recurrent topics in Liana Hsu's work include Diabetes Management and Research (18 papers), Pancreatic function and diabetes (11 papers) and Diabetes and associated disorders (8 papers). Liana Hsu is often cited by papers focused on Diabetes Management and Research (18 papers), Pancreatic function and diabetes (11 papers) and Diabetes and associated disorders (8 papers). Liana Hsu collaborates with scholars based in United States, Australia and Ireland. Liana Hsu's co-authors include Bruce A. Buckingham, Laya Ekhlaspour, Marc D. Breton, R. Paul Wadwa, Gregory P. Forlenza, Mary C. Oliveri, Mark D. DeBoer, Lori Carria, Emma Emory and Melissa J. Schoelwer and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and Diabetes.

In The Last Decade

Liana Hsu

17 papers receiving 594 citations

Hit Papers

A Randomized Trial of Closed-Loop Control in Children wit... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liana Hsu United States 11 567 448 370 27 22 18 612
Ingrid Schütz-Fuhrmann Austria 7 507 0.9× 377 0.8× 325 0.9× 26 1.0× 12 0.5× 15 568
Emily Jost United States 7 510 0.9× 412 0.9× 356 1.0× 13 0.5× 13 0.6× 13 548
Sara Charleer Belgium 10 655 1.2× 399 0.9× 418 1.1× 22 0.8× 13 0.6× 21 693
Yongjin Xu United States 11 442 0.8× 247 0.6× 272 0.7× 30 1.1× 8 0.4× 26 470
Carla M. Frewen New Zealand 8 390 0.7× 303 0.7× 259 0.7× 18 0.7× 16 0.7× 13 419
Judy Sibayan United States 9 392 0.7× 305 0.7× 263 0.7× 9 0.3× 10 0.5× 21 418
Tomas C. Walker United States 11 272 0.5× 154 0.3× 161 0.4× 39 1.4× 25 1.1× 23 325
Renee A. Meier New Zealand 5 335 0.6× 265 0.6× 218 0.6× 15 0.6× 13 0.6× 9 356
Jonathan Burdick United States 6 372 0.7× 289 0.6× 240 0.6× 14 0.5× 20 0.9× 8 418
G Faber-Heinemann Germany 4 378 0.7× 241 0.5× 248 0.7× 16 0.6× 15 0.7× 5 409

Countries citing papers authored by Liana Hsu

Since Specialization
Citations

This map shows the geographic impact of Liana Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liana Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liana Hsu more than expected).

Fields of papers citing papers by Liana Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liana Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liana Hsu. The network helps show where Liana Hsu may publish in the future.

Co-authorship network of co-authors of Liana Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Liana Hsu. A scholar is included among the top collaborators of Liana Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liana Hsu. Liana Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ritschel, Tobias, Ajenthen G. Ranjan, Liana Hsu, et al.. (2024). Impact of Missed and Late Meal Boluses on Glycemic Outcomes in Automated Insulin Delivery-Treated Children and Adolescents with Type 1 Diabetes: A Two-Center, Population-Based Cohort Study. Diabetes Technology & Therapeutics. 26(12). 897–907. 4 indexed citations
2.
Davis, Georgia M., Michael S. Hughes, Sue A. Brown, et al.. (2023). Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial. Diabetes Technology & Therapeutics. 25(10). 677–688. 19 indexed citations
3.
Hsu, Liana, Sue A. Brown, Laura Kollar, et al.. (2022). Smartwatch gesture‐based meal reminders improve glycaemic control. Diabetes Obesity and Metabolism. 24(8). 1667–1670. 20 indexed citations
4.
Anderson, Stacey M., Lisa Norlander, Grenye O’Malley, et al.. (2021). Impact of a Novel Diabetes Support System on a Cohort of Individuals With Type 1 Diabetes Treated With Multiple Daily Injections: A Multicenter Randomized Study. Diabetes Care. 45(1). 186–193. 26 indexed citations
5.
Lal, Rayhan, et al.. (2021). Longevity of the novel ConvaTec infusion set with Lantern technology. Diabetes Obesity and Metabolism. 23(8). 1973–1977. 17 indexed citations
6.
Forlenza, Gregory P., Bruce A. Buckingham, Jennifer L. Sherr, et al.. (2020). 978-P: Omnipod Personalized MPC Algorithm at Target Glucose of 110mg/dl Is Safe in Adults and Adolescents without Increasing Risk of Hypoglycemia. Diabetes. 69(Supplement_1).
7.
Hsu, Liana, Bruce A. Buckingham, Marina Basina, et al.. (2020). Fast-Acting Insulin Aspart Use with the MiniMed TM 670G System. Diabetes Technology & Therapeutics. 23(1). 1–7. 44 indexed citations
8.
Ekhlaspour, Laya, Melissa J. Schoelwer, Gregory P. Forlenza, et al.. (2020). Safety and Performance of the Tandem t:slim X2 with Control-IQ Automated Insulin Delivery System in Toddlers and Preschoolers. Diabetes Technology & Therapeutics. 23(5). 384–391. 35 indexed citations
9.
Ekhlaspour, Laya, Gregory P. Forlenza, Melissa J. Schoelwer, et al.. (2020). 195-OR: Safety and Performance of the Tandem T:slim X2 with Control-IQ Automated Insulin Delivery System in Preschoolers, Age 2-6 Years Old. Diabetes. 69(Supplement_1). 2 indexed citations
10.
Breton, Marc D., Lauren Kanapka, Roy W. Beck, et al.. (2020). A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. New England Journal of Medicine. 383(9). 836–845. 284 indexed citations breakdown →
11.
Kanapka, Lauren, R. Paul Wadwa, Marc D. Breton, et al.. (2020). Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes. Diabetes Care. 44(2). 473–478. 29 indexed citations
12.
Sherr, Jennifer L., Bruce A. Buckingham, Gregory P. Forlenza, et al.. (2019). Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions. Diabetes Technology & Therapeutics. 22(3). 174–184. 60 indexed citations
13.
Anderson, Stacey M., Bruce A. Buckingham, Marc D. Breton, et al.. (2019). Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia. Diabetes Technology & Therapeutics. 21(6). 356–363. 46 indexed citations
14.
Lal, Rayhan, et al.. (2019). 127-LB: Longevity of the Coated ConvaTec Infusion Set with Lantern Technology. Diabetes. 68(Supplement_1). 3 indexed citations
15.
Ekhlaspour, Laya, Gregory P. Forlenza, Cari Berget, et al.. (2019). 1063-P: First Test of the iLet, a Purpose-Built Bionic Pancreas Platform, in Children and Adolescents with Type 1 Diabetes. Diabetes. 68(Supplement_1). 1 indexed citations
16.
Jafri, Rabab, COURTNEY A. BALLIRO, Mallory Hillard, et al.. (2019). 77-OR: First Human Study Testing the iLet, a Purpose-Built Bionic Pancreas Platform. Diabetes. 68(Supplement_1). 5 indexed citations
17.
Norlander, Lisa, Stacey M. Anderson, Carol J. Levy, et al.. (2018). Late and Missed Meal Boluses with Multiple Daily Insulin Injections. Diabetes. 67(Supplement_1). 16 indexed citations
18.
O’Malley, Grenye, Selassie Ogyaadu, David W. Lam, et al.. (2018). Trends in Insulin Pen Priming. Diabetes. 67(Supplement_1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026